1. Home
  2. AUDC vs CGEN Comparison

AUDC vs CGEN Comparison

Compare AUDC & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$10.14

Market Cap

245.9M

Sector

Utilities

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.63

Market Cap

256.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
CGEN
Founded
1992
1993
Country
Israel
Israel
Employees
N/A
75
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.9M
256.2M
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
AUDC
CGEN
Price
$10.14
$2.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.50
$5.00
AVG Volume (30 Days)
83.9K
555.5K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
4.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.24
N/A
Revenue Next Year
$2.18
$75.09
P/E Ratio
$23.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$1.23
52 Week High
$11.48
$3.24

Technical Indicators

Market Signals
Indicator
AUDC
CGEN
Relative Strength Index (RSI) 71.85 51.91
Support Level $8.45 $1.45
Resistance Level $10.47 $3.24
Average True Range (ATR) 0.31 0.17
MACD 0.07 -0.05
Stochastic Oscillator 87.70 15.11

Price Performance

Historical Comparison
AUDC
CGEN

About AUDC AudioCodes Ltd.

AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: